Polyethylene Glycol afternoon — Competitive Intelligence Brief

Polyethylene Glycol afternoon (Polyethylene Glycol afternoon) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Osmotic laxative. Area: Gastrointestinal.

phase 3 Osmotic laxative Gastrointestinal Small molecule

Target snapshot

Polyethylene Glycol afternoon (Polyethylene Glycol afternoon) — Cleveland Clinic Florida. Polyethylene Glycol works by increasing the amount of water in the stool to make it easier to pass.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Polyethylene Glycol afternoon TARGET	Polyethylene Glycol afternoon	Cleveland Clinic Florida	phase 3	Osmotic laxative
Pizensy	LACTITOL	Braintree Labs	marketed	Osmotic Laxative		2020-01-01
Miralax	Macrogol	Braintree	marketed	Osmotic Laxative [EPC]		1984-01-01
Cephulac	LACTULOSE	Sanwa Kagaku Kenkyusho Co., Ltd.	marketed	Osmotic Laxative [EPC]		1976-01-01
Milk of Magnesia	magnesium hydroxide	Generic (multiple manufacturers)	marketed	Osmotic laxative, Antacid	Gastric acid (direct neutralization) + osmotic effect in intestine	1880-01-01
Polyethylene Glycol 4000 with electrolytes	Polyethylene Glycol 4000 with electrolytes	Fundación Pública Andaluza para la gestión de la Investigación en Sevilla	marketed	Osmotic laxative
Polyethylene glycol / Ascorbic acid	Polyethylene glycol / Ascorbic acid	Tomas Bata Hospital, Czech Republic	marketed	Osmotic laxative with antioxidant supplement

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

• 2032-03-09 — Miralax · 10780112 · US
• 2032-03-09 — Miralax · 11529368 · US
• 2032-03-09 — Miralax · 10792306 · US
• 2032-03-25 — Miralax · 10646512 · US
• 2032-08-11 — Miralax · 9592252 · US
• 2033-09-10 — Miralax · 9326969 · US
• 2033-09-10 — Miralax · 9707297 · US
• 2033-09-10 — Miralax · 8999313 · US
• 2033-09-10 — Miralax · 10918723 · US
• 2033-09-10 — Miralax · 10016504 · US

Sponsor landscape (Osmotic laxative class)

1. Brooke Army Medical Center · 2 drugs in this class
2. Cleveland Clinic Florida · 2 drugs in this class
3. Gastroenterology Services, Ltd. · 2 drugs in this class
4. Ipsen · 2 drugs in this class
5. Benaroya Research Institute · 1 drug in this class
6. Bo-In Lee · 1 drug in this class
7. Amsterdam UMC, location VUmc · 1 drug in this class
8. C.B. Fleet Company, Inc. · 1 drug in this class
9. Bayer · 1 drug in this class
10. Braintree Laboratories · 1 drug in this class